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Abstract: We herein report the case of a 20-year-old man who underwent a photorefractive 
keratectomy (PRK). We measured matrix metalloproteinase-9 (MMP-9) activity and   chondroitin 
4 sulfate and chondroitin 6 sulfate concentrations in tear fluid. Tear fluid was collected pre-
operatively via microcapillary tube, and was collected postoperatively on the first and fourth 
days, and after one week, one month, three months, and six months. Samples were formulated 
by dilution with 200 µL of saline. MMP-9 activity was analyzed by an enzyme immunocapture 
activity assay, and the concentrations of chondroitin sulfate were analyzed by enzyme-linked 
immunosorbent assay. No complications were observed after surgery, except for a minimal 
subepithelial haze. Although MMP-9 activity changed on the fourth postoperative day, the 
activity changed only minimally at this time. Chondroitin 4 sulfate concentrations in tear fluid 
increased dramatically from one week to one month, decreased transiently at three months, and 
increased by six months. The chondroitin 6 sulfate concentration did not normalize within one 
week, and decreased from one week to three months compared with the preoperative score, 
and was close to the preoperative score at six months. We conclude that corneal wound   healing 
was still incomplete six months after PRK, and chondroitin 4 sulfate appears to be critical in 
this process.
Keywords: matrix metalloproteinase, chondroitin sulfate, human tear fluid, photorefractive 
keratectomy, corneal wound healing
Introduction
Matrix metalloproteinases (MMPs) are proteases that degrade collagen, a basement 
membrane constituent, and other components in the extracellular matrix.1 MMPs are 
important in tissue remodeling and wound healing.2 Twenty-eight types of MMPs are 
identified today. MMP-9 degrades collagens, fibronectin, elastin, and gelatins.3
Chondroitin sulfate is a component of the extracellular matrix that participates 
in tissue and wound healing in various organs, and has isomers containing sulfate, 
chondroitin 4 sulfate (C4S), and chondroitin 6 sulfate (C6S).4–6 Chondroitin sulfate 
is assumed to have a connection with matrix metalloproteinases (MMPs) because 
chondroitin sulfate affects the expression and activation of MMP in vitro,7 which 
decomposes the extracellular matrix.1
The use of laser refractive surgery has increased recently, and has become a   subject 
of study as a model of corneal wound healing because it necessitates injury to the 
cornea.4,8–11 Photorefractive keratectomy (PRK) is a type of laser refractive   surgery, 
and tends to induce a haze after surgery. A large amount of extracellular matrix accu-
mulates in the haze on rabbit cornea.8 Holopainen et al have reported alteration in Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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MMP-8 levels in tear fluid before and after PRK.10 Based 
on these findings, we collected tear fluid from the eyes of a 
patient who underwent PRK and measured MMP-9 activity 
and chondroitin sulfate concentrations in both eyes using an 
enzyme immunocapture activity assay (EIA) and an enzyme-
linked immunosorbent assay (ELISA), respectively.
Case report
A 20-year-old man was referred to our institution to cor-
rect myopic astigmatism. The patient’s uncorrected visual 
acuity was 0.03 in the right eye and 0.09 in the left eye. 
The patient’s best corrected visual acuity was 2.0   (corrected 
with -7.50 D sph) in the right eye and 2.0 (corrected 
with -6.50 D sph -0.50 D cyl, axis 170°) in the left eye. 
The intraocular pressure was 13 mmHg in the right eye and 
11 mmHg in the left eye. No abnormalities were found in the 
anterior segment of the eye, ocular media, or ocular fundus. 
PRK was planned because the patient wished to become a 
boxer. Informed consent was obtained from the patient after 
he received a detailed verbal explanation of the study prior 
to tear sample collection, in accordance with the 2000 World 
Medical Association Declaration of Helsinki.
Photorefractive keratectomy
Simultaneous binocular PRK was performed for emmetro-
pia. The VISXR Star S3 excimer laser (VISX®, USA Inc.; 
wavelength 193 nm, fluence 160 mJ/cm2, and pulse rate 
10 Hz) was used. The eye tracking system in the excimer 
laser was active during the procedure. The planned laser abla-
tion was performed on the Bowman membrane and corneal 
stroma after surgical ablation of the epithelium. The ablation 
diameter was 6.5 mm, and the ablation depth was 108 µm in 
the right eye and 96 µm in the left eye.
The surgical field was washed using 0.3 mM oxyglu-
tathione solution after laser ablation, and disposable soft 
contact lenses were worn in both eyes. No complications 
were observed during surgery. After the procedure, 0.5% 
levofloxacin and betamethasone sodium phosphate 0.1% 
were administered into the eyes.
Postoperative course
The patients received levofloxacin 0.5%, fluorometholone 
0.1%, and sodium hyaluronate four times daily for one week 
after surgery. One week later, levofloxacin 0.5% and fluo-
rometholone 0.1% were tapered to twice daily and discon-
tinued one month postoperatively, and sodium hyaluronate 
0.3% was applied as needed. Four days later, the contact 
lenses were removed from the eyes. Although   postoperative 
minimal haze was observed after one month, no effect was 
observed on the patient’s visual acuity or refraction. The 
patient’s uncorrected bilateral visual acuity was 1.5 and 
his best corrected bilateral visual acuity was 2.0 (corrected 
with -0.50 D sph) at six months postoperatively.
Methods
samples
Tear fluid was collected from the lower conjunctival sac with 
a microcapillary tube (Minicaps, Hirschmann Laborgerate, 
capillary length 32 mm, maximum volume 0.5 µL). To 
  prevent conjunctival stimulation and reflex tearing, care was 
taken not to touch the conjunctiva. The collection time was 
30 seconds. When the capillary filled with tear fluid within 
30 seconds, additional capillaries were applied immediately 
to the conjunctival sac until 30 seconds had elapsed. No 
topical anesthesia was applied during the collection process, 
and no topical agents were used in the 30 minutes prior to 
collection of the tear fluid. The tear volume was calculated 
by measuring the height of the tear fluid in the microcapillary 
tube. We   collected 0.3–3.0 µL of tear fluid from each eye and 
formulated the samples by diluting the collected tear fluid 
with 200 µL of saline. The samples were frozen   immediately 
at -40°C after collection until the measurements were 
  performed. Tear fluid was collected preoperatively and then 
postoperatively on the first and fourth days, and at the end of 
the first week, and at one, three, and six months. All samples 
were collected by the same investigator.
MMP-9 activity and chondroitin 
sulfate levels
The activity of MMP-9 in the tear fluid was measured by 
EIA and the concentrations of each chondroitin sulfate iso-
mer were measured by a sandwich ELISA, which we have 
previously reported.4,14 We describe the main aspects of each 
measurement method below.
MMP-9 is produced as a pro-MMP-9 inside the cell. It is 
released into the extracellular space and converted to active 
MMP-9, which decomposes the extracellular matrix. Only 
active-type MMP-9 activity can be measured by EIA.
The sandwich ELISA method was modified to improve 
the accuracy of measuring low chondroitin sulfate. The 
standard chondroitin sulfate solution used in the ELISA was 
comprised of heterogeneous polysaccharides, which were 
extracted from dogfish cartilage and purified. Antibodies 
to C4S and C6S were used as the primary antibodies. The 
epitope of these antibodies is a 4- to 5-polysaccharide chain 
in chondroitin sulfate. Chondroitin sulfates with more than Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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8- to10-polysaccharide chains in the tear fluid can be detected 
in the sandwich ELISA.
Results
Figures 1 to 3 show the postoperative changes in MMP-9 
activity and chondroitin sulfate concentrations, respectively. 
MMP-9 activity did not renormalize within four days, and 
was changed slightly at this time compared with preoperative 
levels. The C4S concentration increased dramatically from 
the first week to one month, was decreased at three months, 
and increased at six months. The C6S concentration did not 
normalize within one week, decreased from the first week 
to three months from the preoperative score, and got closer 
to the preoperative score at six months, but did not actually 
reach it.
Discussion
Although MMP-9 activity in the tear fluid was changed on 
the first postoperative day, the levels were changed only 
minimally from the preoperative value after four days. 
MMP-9 may participate in corneal wound healing shortly 
after PRK, whereas the MMP-8 concentrations have been 
found to be significantly higher in patients undergoing PRK 
than in control subjects on the second postoperative day.10 
This may indicate that MMP-8 and MMP-9 participate in 
different phases of corneal wound healing. The changes in 
the right and left eye were different on the first postoperative 
day. We will need to perform more of these procedures to 
clarify this finding.
In contrast, the C4S concentration in the tear fluid 
changed dramatically. These changes indicated that C4S 
can participate greatly in corneal wound healing following 
PRK. However, Oya et al have reported that C4S did not 
show any significant variation in tear fluid in a rabbit model 
of wound healing.5 We performed PRK on the human cornea 
with an excimer laser, but Oya et al performed a scrape on 
the rabbit corneal epithelium with a trephine and spatula.5 
The present study differs from the report by Oya et al5 
in the use of materials and surgical procedures. Nakayasu 
et al have reported that the wound healing process was still 
incomplete three years after PRK in rabbits.9 Increased 
C4S concentrations six months postoperatively indicate 
that the wound healing process was still incomplete. The 
C6S concentration in the tear fluid was still abnormal at 
one week, and levels decreased from the first week to three 
months following the preoperative collection. These changes 
indicate that C6S seems to be implicated in corneal wound 
healing following PRK, and that low C6S levels activate the 
extracellular matrix, and can affect corneal wound healing 
as a result.
Contact lenses affect the ocular surface.11 Disposable 
soft contact lenses worn for four days following PRK might 
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Figure 1 Changes in matrix metalloproteinase-9 in tear fluid after photorefractive 
keratectomy. The vertical axis represents the matrix metalloproteinase-9 activity, 
and the horizontal axis represents time.
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Figure  2  Changes  in  chondroitin  4  sulfate  in  tear  fluid  after  photorefractive 
keratectomy. The vertical axis represents the chondroitin 4 sulfate concentration, 
the horizontal axis is time.
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Figure  3  Changes  in  chondroitin  6  sulfate  in  tear  fluid  after  photorefractive 
keratectomy. The vertical axis represents the chondroitin 6 sulfate concentration, 
the horizontal axis is time.Clinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
1018
Mutoh et al
therefore affect tear secretion, tear exchange, and tear 
  distribution.11 These changes might affect MMP-9   activity 
and concentrations during corneal wound healing. The 
administration of topical corticosteroids following PRK is 
another factor that affects corneal wound healing. However, 
the stability of refraction and the occurrence of haze are not 
frequently observed.12,13 Therefore, topical corticosteroids 
do not seem to play a beneficial role in MMP-9 activity 
and chondroitin sulfate concentration in corneal wound 
healing.
MMPs are inhibited by naturally-occurring proteins, 
tissue inhibitors of MMPs, and by the broad-spectrum 
inhibitor, α2-macroglobulin.1 MMPs are synthesized 
  primarily by connective tissue cells, granulocytes, and 
monocyte macrophages,1 and are present in various body 
fluids, including tears.1,2 The tear fluid is formed from the 
lipid layer, aqueous layer, and mucous layer. It also shields 
the cornea from the environment, and is essential for corneal 
transparency.4 MMP-9, C4S, and C6S are present in normal 
human tear fluid.1,4,6,14,15 During corneal wound healing, 
MMP contributes to the synthesis and decomposition of 
the extracellular matrix.16 Based on these findings, MMPs 
will interact with factors such as tissue inhibitors of MMPs, 
the extracellular matrix, and chondroitin sulfate, which are 
well balanced and participate actively in the corneal wound 
healing process.
We conclude that corneal wound healing was still 
incomplete six months after PRK, and C4S in tear fluid may 
participate in corneal wound healing after PRK in particular. 
The changes in MMP-9 activity and chondroitin sulfate con-
centrations may be correlated with problems following PRK, 
such as visual haze caused by a large amount of extracellular 
matrix deposits. To reduce these complications, further stud-
ies will examine MMP-9 and chondroitin sulfate levels in 
tear fluid in the future.
Disclosure
The authors report no conflict of interest in this work.
References
  1.  Leonardi A, Brun P, Abatangelo G, et al. Tear levels and activity of 
matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratocon-
junctivitis. Invest Ophthalmol Vis Sci. 2003;44:3052–3058.
  2.  Hanemaaijer R, Visser H, Konttinen YT, et al. A novel and simple 
immunocapture assay for determination of gelatinase-B (MMP-9) 
activities in biological fluids: Saliva from patients with Sjögren’s syn-
drome contain increased latent and active gelatinase-B levels. Matrix 
Biol. 1998;17:657–665.
  3.  Kobayashi T. Role of matrix metalloproteinase-9 expression on cuta-
neous inflammation: Possible treatment by leptomycin B application. 
Inflammation and Regeneration. 2004;24:578–583.
  4.  Nishio M, Arai K. Quantitative analysis of chondroitin sulfate in tear 
fluids following laser in situ keratomileusis. Ophthalmic Res. 2006; 
38:274–279.
  5.  Oya T, Obata H, Miyata K, et al. Quantitative analysis of glycosamino-
glycans in tear fluids during corneal epithelial wound healing in rabbits. 
Jpn J Ophthalmol Soc. 1994;98:1049–1055.
  6.  Oya T, Obata H, Miyata K, et al. Quantitative analysis of glycosamino-
glycans in tear fluids in normal human eyes and eyes with corneal 
epithelial disorders. Jpn J Ophthalmol Soc. 1995;99:302–307.
  7.  Isnard N, Robert L, Renard G. Effect of sulfated GAGs on the expression 
and activation of MMP-2 and MMP-9 in corneal and dermal explant 
cultures. Cell Biol Int. 2003;27:779–784.
  8.  Nakayasu K, Gotoh T, Ishikawa T, et al. Glycosaminoglycans in sub-
epithelial opacity after excimer laser keratectomy. Jpn J Ophthalmol 
Soc. 1996;100:350–357.
  9.  Nakayasu K, Watanabe Y, Gotoh T, et al. Long-term healing of exci-
mer laser ablated rabbit corneas. Jpn J Ophthalmol Soc. 1999;103: 
99–107.
  10.  Holopainen JM, Moilanen JAO, Sorsa T, et al. Activation of matrix 
metalloproteinase-8 by membrane type 1-MMP and their expression 
in human tears after photorefractive keratectomy. Invest Ophthalmol 
Vis Sci. 2003;44:2550–2556.
  11.  Kinoshita S, Maruyama K, Komuro A, et al. The ocular surface and 
contact lens wear. J Jpn CL Soc. 2003;45:2–10.
  12.  Corbett MC, O’Brart DP, Marshall J. Do topical corticosteroids have 
a role following excimer laser photorefractive keratectomy? J Refract 
Surg. 1995;11:380–387.
  13.  Baek SH, Chang JH, Choi SY, et al. The effect of topical corticosteroids 
on refractive outcome and corneal haze after photorefractive keratec-
tomy. J Refract Surg. 1997;13:644–652.
  14.  Mutoh T, Nishio M, Matsumoto Y, et al. Correlation between the 
matrix metalloproteinase-9 activity and chondroitin sulfate concentra-
tions in tear fluid after laser in situ keratomileusis. Clin Ophthalmol. 
(In press).
  15.  Sobrin L, Liu Z, Monroy DC, et al. Regulation of MMP-9 activity 
in human tear fluid and corneal epithelial culture supernatant. Invest 
Ophthalmol Vis Sci. 2000;41:1703–1709.
  16.  Matsubara M, Girard MT, Kublin CL, et al. Differential roles for two 
gelatinolytic enzymes of the matrix metalloproteinase family in the 
remodeling cornea. Dev Biol. 1991;147:425–439.